Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Diphtheria to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Diphtheria to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Diphtheria Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 35
Appendix 217
Abbreviations 217
Definitions 217
Research Methodology 218
Secondary Research 218
About GlobalData 219
Contact Us 219
Source 219

List of Tables
Diphtheria Therapeutics, Global, Clinical Trials by Region, 2017* 7
Diphtheria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Diphtheria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Diphtheria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Diphtheria Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Diphtheria Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Diphtheria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Diphtheria Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Diphtheria to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16
Diphtheria Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Diphtheria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Diphtheria to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
Diphtheria Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Diphtheria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Diphtheria Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Diphtheria Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Diphtheria Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Diphtheria Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Diphtheria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Diphtheria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Diphtheria Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Diphtheria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Diphtheria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 34

List of Figures
Diphtheria Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Diphtheria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Diphtheria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Diphtheria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Diphtheria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Diphtheria Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Diphtheria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Diphtheria Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Diphtheria to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 16
Diphtheria Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Diphtheria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Diphtheria to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 19
Diphtheria Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Diphtheria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Diphtheria Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Diphtheria Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Diphtheria Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Diphtheria Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Diphtheria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Diphtheria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
Diphtheria Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Diphtheria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Diphtheria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
GlobalData Methodology 218

Companies Mentioned
- GlaxoSmithKline Plc
- Sanofi
- Merck & Co Inc
- Panacea Biotec Ltd
- Sanofi Pasteur MSD SNC
- Serum Institute of India Ltd
- LG Life Science LTD
- PT Bio Farma
- Novartis AG
- Cadila Healthcare Ltd